ERBB2 (HER2) Testing in Breast Cancer

被引：5
|
作者：
Hilal, Talal [1 ]
Romond, Edward H. [2 ]
机构：
[1] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Markey Canc Ctr, Div Med Oncol, Lexington, KY 40536 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 315卷 / 12期
关键词：
NCCTG N9831; SURVIVAL;
D O I：
10.1001/jama.2015.17463
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1280 / 1281
页数：2
相关论文
共 50 条
  • [31] Acral lentiginous melanoma with HER2/ErbB2 amplification
    Donzel, Marie
    Harou, Olivier
    Skowron, Francois
    Dalle, Stephane
    Descotes, Francoise
    Balme, Brigitte
    Lopez, Jonathan
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (04) : 588 - 590
  • [32] Prognostic value of ErbB2/HER2 in human meningiomas
    Arnli, Magnus B.
    Winther, Theo L.
    Lydersen, Stian
    Torp, Sverre H.
    PLOS ONE, 2018, 13 (10):
  • [33] HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer
    Xia, Daniel
    Kuo, Frank
    Hughes, Melissa
    Lindeman, Neal
    Manning, Danielle
    Files, Janet
    Strauss, Sarah
    Kirkner, Greg
    Mohammed-Abreu, Ayesha
    Winer, Eric
    Tolaney, Sara M.
    Lin, Nancy U.
    Dillon, Deborah A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (05) : 436 - 442
  • [34] Activating mutations in ERBB2/HER2 as found by FoundationOneTM represent potential therapeutic targets in breast cancer
    Palmer, Gary A.
    Ross, Jeffrey S.
    Wang, Kai
    Frampton, Garrett M.
    Ali, Siraj M.
    Palma, Norma
    Morosini, Deborah
    Miller, Vincent A.
    Yelensky, Roman
    Lipson, Doron
    Stephens, Philip J.
    Chmielecki, Juliann
    CANCER RESEARCH, 2015, 75
  • [35] Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases
    Mo, Dun-Chang
    Luo, Peng-Hui
    Huang, Jian-Feng
    JAMA ONCOLOGY, 2023, 9 (07) : 1008 - 1009
  • [36] Breast Cancer HER2 (ERBB2) Status by Next-Generation Sequencing Compared to Traditional Methods
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lyle, Stephen
    Tse, Julie Y.
    LABORATORY INVESTIGATION, 2018, 98 : 103 - 103
  • [37] Breast Cancer HER2 (ERBB2) Status by Next-Generation Sequencing Compared to Traditional Methods
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lyle, Stephen
    Tse, Julie Y.
    MODERN PATHOLOGY, 2018, 31 : 103 - 103
  • [38] Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases
    Priedigkeit, Nolan
    Hartmaier, Ryan J.
    Chen, Yijing
    Vareslija, Damir
    Basudan, Ahmed
    Watters, Rebecca J.
    Thomas, Roby
    Leone, Jose P.
    Lucas, Peter C.
    Bhargava, Rohit
    Hamilton, Ronald L.
    Chmielecki, Juliann
    Puhalla, Shannon L.
    Davidson, Nancy E.
    Oesterreich, Steffi
    Brufsky, Adam M.
    Young, Leonie
    Lee, Adrian V.
    JAMA ONCOLOGY, 2017, 3 (05) : 666 - 671
  • [39] Pan-cancer analysis of the influence of ERBB2 alteration on HER2 expression
    Lee, Taebum
    Shin, Sangwon
    Song, Heon
    Park, Seonwook
    Pereira, Sergio
    Yoo, Donggeun
    Ro, Juneyoung
    Moon, Jimin
    Cho, Soo Ick
    Ahn, Changho
    Ock, Chan-Young
    Ali, Siraj M.
    CANCER RESEARCH, 2023, 84 (06)
  • [40] ERBB2 mRNA expression in HER2-low breast cancer
    Teng, X.
    Li, X.
    Xu, S.
    Zhang, J.
    Bai, Y.
    Ba, X.
    Wu, Z.
    Liu, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S93 - S93
12345